Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thompson Tamar Insider Profile
4 Followers
Thompson Tamar, Director at Avidity Biosciences, holds 1.41K shares in Catalyst Pharma (Ticker: CPRX), holds 0.00 shares in Avidity Biosciences (Ticker: RNA).
Thompson Tamar has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thompson Tamar holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thompson Tamar
Thompson Tamar's Trading History
Avidity Biosciences
Oct 09, 2024
Director
Uninformative Buy
828.90K
$0.00
Catalyst Pharma
Dec 11, 2024
Director
Uninformative Buy
30.72K
$30.32K
List of latest transactions for each holding click on a transaction to see Thompson Tamar's performance on stock
You May Also Like
Thompson Tamar insider profile FAQ
What is the percentage of profitable transactions made by Thompson Tamar?
The percentage of profitable transactions made by Thompson Tamar is ―.
What is the average return per transaction made by Thompson Tamar?
The average return per transaction made by Thompson Tamar is ―.
What stocks does Thompson Tamar hold?
Thompson Tamar holds: RNA, CPRX stocks.
What was Thompson Tamar’s latest transaction?
Thompson Tamar latest transaction was an Uninformative Buy of $30.72K.
What was Thompson Tamar's most profitable transaction?
Thompson Tamar’s most profitable transaction was an Informative Sell of RNA stock on October 9, 2024. The return on the trade was 16.30%.
What is Thompson Tamar's role in Avidity Biosciences?
Thompson Tamar's role in Avidity Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.